Boston, MA -- (SBWIRE) -- 08/29/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (McDermott International (NYSE:MDR), ARMOUR Residential REIT, Inc.(NYSE:ARR), Northstar Realty Finance Corp. (NYSE:NRF), Halozyme Therapeutics, Inc. (NASDAQ:HALO)
McDermott International (NYSE:MDR) shares increased 1.19% to $7.64. Glancy Binkow & Goldberg LLP on August 20 announces that a class action lawsuit has been filed in the United States District Court for the Southern District of Texas on behalf of a class comprising all purchasers of the common stock of McDermott International, between November 6, 2012 and August 5, 2013, inclusive.
Additionally, the company issued its quarterly earnings data on August 6. The company reported ($0.63) earnings per share for the quarter, missing the analysts’ consensus estimate of $0.03 by $0.66. The company had revenue of $647.25 million for the quarter, compared to the consensus estimate of $757.87 million.
Is MDR A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
ARMOUR Residential REIT, Inc.(NYSE:ARR) shares fell 0.48% to $4.12. The company on August 27 announced that the Board of Directors has appointed Ms. Carolyn Downey as a new independent member of the Board of Directors of the Company, effectiveSeptember 3, 2013.
With the appointment of Ms. Downey, the Company expects to regain compliance with Section 303A.01 of the New York Stock Exchange Listed Company Manual and Section 802(a) of the NYSE MKT LLC Company Guide, both which require a majority of independent directors on the Company's Board of Directors.
Is ARR A Good Buy After The Recent Price Movement? Find Out Here
Northstar Realty Finance Corp. (NYSE:NRF) shares closed at $8.66. The company, on August 16, announced that NorthStar Real Estate Income Trust, Inc., its first sponsored non-traded REIT, successfully priced a $531.5 million non-recourse, floating-rate CMBS transaction at a weighted average coupon of LIBOR + 2.68%. The CMBS transaction will initially be collateralized by $425.2 million of commercial real estate loans with the flexibility to contribute up to $106.3 million of additional commercial real estate loans within six months of closing.
How Should Investors Trade NRF After The Recent Volatility? Get Free Report Here
Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares climbed 10.60% to $8.14. The company, on Aug. 7, reported financial results for the quarter and six months ended June 30, 2013. Financial highlights for the second quarter include revenues of $14.5 million and a net loss of $22.9 million or $0.20 per share. This compares to revenues of $7.8 million and a net loss of $14.0 million or $0.13 per share for the second quarter of 2012.
How Should Investors Trade HALO After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)